MARKET

NMTR

NMTR

9 Meters Biopharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4982
-0.0068
-1.35%
After Hours: 0.4924 -0.0058 -1.16% 19:34 08/07 EDT
OPEN
0.5146
PREV CLOSE
0.5050
HIGH
0.5175
LOW
0.4934
VOLUME
356.93K
TURNOVER
--
52 WEEK HIGH
1.290
52 WEEK LOW
0.3701
MARKET CAP
67.87M
P/E (TTM)
-0.6889
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NMTR stock price target is 5.00 with a high estimate of 5.00 and a low estimate of 5.00.

EPS

NMTR News

More
9 Meters Biopharma shares are trading higher after the company announced the issuance of a patent for the use of Larazotide in acute lung injury and acute respiratory distress syndrome. NOTE: Shares have reversed since then.
Benzinga · 07/28 13:41
9 Meters Bio nabs new patent for larazotide in U.S.
Seeking Alpha · 07/28 12:07
9 Meters Biopharma, Inc. Announces Issuance Of Patent For Use Of Larazotide In Acute Lung Injury (ALI) And Acute Respiratory Distress Syndrome (ARDS)
U.S. Pat. No. 10,723,763 issued on July 28, 2020, shows Larazotide reduces endothelial barrier permeability in a dose dependent fashion in both ALI and ARDS RALEIGH, NC / ACCESSWIRE / July 28, 2020 / 9 Meters
Benzinga · 07/28 11:34
9 Meters Biopharma initiates mid-stage study for NM-002 in short bowel syndrome
9 Meters Biopharma (NMTR +5.4%) has dosed first patients in a Phase 1b/2a trial to evaluate NM-002 in adults with short bowel syndrome (SBS). NM-002 is an
seekingalpha · 07/21 20:09
9 Meters Biopharma, Inc. Doses First Patients In Phase 1b/2a Clinical Trial In Short Bowel Syndrome
NM-002 is a long-acting GLP-1 agonist designed to address the gastric effects in SBS patients by slowing digestive transit time RALEIGH, NC / ACCESSWIRE / July 21, 2020 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a
Benzinga · 07/21 11:48
80 Biggest Movers From Yesterday
Gainers Equillium, Inc. (NASDAQ: EQ) shares surged 730.7% to close at $26.50 on Monday after the company disclosed that Itolizumab significantly reduced mortality in coronavirus patients, according to a clinical trial conducted in India by its partner Biocon.
Benzinga · 07/14 09:11
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating 9 Meters Biopharma, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of 9 Meters Biopharma, Inc. (NASDAQ: NMTR).
PR Newswire · 07/13 14:26
SunTrust Robinson Humphrey Initiates Coverage On 9 Meters Biopharma with Buy Rating, Announces Price Target of $5
SunTrust Robinson Humphrey analyst Srikripa Devarakonda initiates coverage on 9 Meters Biopharma (NASDAQ:NMTR) with a Buy rating and announces Price Target of $5.
Benzinga · 06/30 12:07

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About NMTR

9 Meters Biopharma, Inc., formerly Innovate Biopharmaceuticals, Inc., is a gastrointestinal platform company. The Company is focused on developing treatments for patients with rare disorders and unmet needs. Its pipeline includes drug candidates for short bowel syndrome and celiac disease. Its pipeline includes NM-002, Larazotide, NM-003 and NM-004. NM-002 is a long-acting injectable GLP-1 analogue for short bowel syndrome (SBS). Larazotide is an orally administered, gut-restricted tight-junction regulator for celiac disease. NM-003 is a GLP-2 analogue, under orphan indication selection. NM -004 is an immunomodulator, granted pediatric orphan designation in ulcerative colitis.
More

Webull offers kinds of 9 Meters Biopharma Inc stock information, including NASDAQ:NMTR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMTR stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NMTR stock methods without spending real money on the virtual paper trading platform.